$QXL

Baranes Yakov purchased $24K of QXL

Baranes Yakov (Co-CEO) purchased 5,000 shares of QUANTUM X LABS INC. (QXL) at $4.88 on 2026-09-15.

Original reporting
SEC EDGAR · Baranes Yakov
Published Sep 17, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 11:38 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$QXL
Bullish
medium confidence
Mentioned
$QXL
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QXLBullishLow
01

Why it matters

The $24k purchase by a co-CEO provides a modest positive cue but lacks scale to drive trading decisions.

02

Market read

Insider buy is a low‑impact signal; traders should monitor for larger insider activity or corporate news.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed could affect future insider behavior.

Relevance 4/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider trades; small purchases are common and often not market-moving.

Company-level read

Ticker impact

$QXLBullishMedium confidence
Context

Co-CEO Baranes Yakov bought 5,000 shares for $24,400 in a Form 4 filing, indicating insider confidence.

Expected impact

Potential slight upside pressure, unlikely to move price materially.

Evidence & confidence

The transaction size is modest ($24k) and represents a routine insider buy, offering limited actionable insight.

Market effects

Minimal effect on the biotech/tech sector; insider activity is routine.

No discernible regional impact.

Limited relevance beyond the specific ticker.

Counterpoint

The purchase may be a routine portfolio rebalancing, not a strong bullish signal.

Key entities

  • Quantum X Labs Inc.

    Issuer of the Form 4 filing.

  • Baranes Yakov

    Co-CEO and reporting officer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QXLMed

Quantum X Hikes on News of New Director

Quantum X Labs Inc. (QXL) appointed Yossi Cohen, former Mossad director, as President of its Scientific Advisory Board. Cohen will aid in strategic direction for quantum technologies, focusing on defense and security markets. QXL shares rose 14.9% to $4.94 on the news.